Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Findings and insights from the genetic investigation of age of first reported occurrence for complex disorders in the UK Biobank and FinnGen

View ORCID ProfileYen-Chen A. Feng, Tian Ge, Mattia Cordioli, FinnGen, Andrea Ganna, Jordan W. Smoller, Benjamin M. Neale
doi: https://doi.org/10.1101/2020.11.20.20234302
Yen-Chen A. Feng
1Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA
2Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
3Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yen-Chen A. Feng
Tian Ge
1Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA
3Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
4Harvard Medical School, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mattia Cordioli
6Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Ganna
2Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
5Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
6Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan W. Smoller
1Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA
3Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
4Harvard Medical School, Boston, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jsmoller@partners.org bneale@broadinstitute.org
Benjamin M. Neale
2Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
3Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
4Harvard Medical School, Boston, Massachusetts, USA
5Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jsmoller@partners.org bneale@broadinstitute.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Age of onset contains information on the timing of events relevant to disease etiology, but there has not been a systematic investigation of its heritability from GWAS data. Here, we characterize the genetic architecture of age of first occurrence and its genomic relationship with disease susceptibility for a wide range of complex disorders in the UK Biobank. For diseases with a sufficient sample size, we discover that age of first occurrence has non-trivial genetic contributions, some with specific genetic risk factors not associated with susceptibility to the disease. Through genetic correlation analysis, we show that an earlier health-event occurrence is correlated with a higher polygenic risk of disease susceptibility. An independent genetic investigation of the FinnGen cohort replicates the pattern of heritability and genetic correlation estimates. We then demonstrate that incorporating disease onset age with susceptibility may improve genetic risk prediction and stratification.

Competing Interest Statement

J.W.S is an unpaid member of the Bipolar/Depression Research Community Advisory Panel of 23andMe, a member of the Leon Levy Foundation Neuroscience Advisory Board and received an honorarium for an internal seminar at Biogen, Inc. He is PI of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments. B.M.N. is a member of the Deep Genomics Scientific Advisory Board and serves as a consultant for the Camp4 Therapeutics Corporation, Takeda Pharmaceutical and Biogen. The remaining authors declare no conflict of interests.

Funding Statement

We would like to acknowledge the participants and investigators of the UK Biobank and the FinnGen study for their gracious contribution. This research has been conducted using the UK Biobank Resource under Application Numbers 31063 and 32568. T.G. is supported by the National Institutes of Health (NIH) grant K99/R00 AG054573.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The UK Biobank and FinnGen datasets analyzed in the present work were requested through applications and were approved for research use in our study. The UK Biobank Resource is open to the public and was obtained under Application Numbers 31063 and 32568 by our group. For each participant in the UK Biobank, an electronically signed consent was obtained at recruitment, who then provided as part of the data collection their demographic information, health-related conditions as well as biological samples (e.g., blood, saliva) for genetic and other -omics data generation. All the individual-level information in the dataset is de-identified. Our access to the FinnGen study is obtained through a research proposal with Dr. Andrea Ganna, a consortium partner of FinnGen and a co-author of the work, which granted only sharing of results but not individual-level data sharing. All the genetic analyses of the FinnGen cohort presented in the manuscript were performed by Dr. Ganna's group, and the summary tables (e.g, heritability, genetic correlation estimates) were then shared with the first author for plotting and writing purposes. The FinnGen study is a registry-based cohort that includes all Finnish biobanks and hospital-based cohorts in Finland, in which all participants were asked to provide informed consent, either electronically or written, to donate his or her samples before joining the biobank. Both UK Biobank and FinnGen cohorts updates informed consent regularly. Our study has carefully removed any individuals who have since withdrawn consent prior to data analysis.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The UK Biobank data may be obtained through online registration and application (https://www.ukbiobank.ac.uk/). Study details of the FinnGen study cohort may be accessed through Finnish Biobanks' FinnBB portal (www.finbb.fi). GWAS summary statistics of age of first occurrence generated in the study will be made available at a public data repository prior to publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Findings and insights from the genetic investigation of age of first reported occurrence for complex disorders in the UK Biobank and FinnGen
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Findings and insights from the genetic investigation of age of first reported occurrence for complex disorders in the UK Biobank and FinnGen
Yen-Chen A. Feng, Tian Ge, Mattia Cordioli, FinnGen, Andrea Ganna, Jordan W. Smoller, Benjamin M. Neale
medRxiv 2020.11.20.20234302; doi: https://doi.org/10.1101/2020.11.20.20234302
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Findings and insights from the genetic investigation of age of first reported occurrence for complex disorders in the UK Biobank and FinnGen
Yen-Chen A. Feng, Tian Ge, Mattia Cordioli, FinnGen, Andrea Ganna, Jordan W. Smoller, Benjamin M. Neale
medRxiv 2020.11.20.20234302; doi: https://doi.org/10.1101/2020.11.20.20234302

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)